載入...
Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial
BACKGROUND: Hohla et al. suggested that female gender could positively predict response to FOLFIRINOX in patients with advanced pancreatic cancer. In this study, we explored the response to the FOLFIRINOX regimen by gender within the trial PRODIGE4/ACCORD 11. PATIENTS AND METHODS: Data were describe...
Na minha lista:
| 發表在: | PLoS One |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Public Library of Science
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5606928/ https://ncbi.nlm.nih.gov/pubmed/28931010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0183288 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|